Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag and Platelet Survival in ITP
NCT00902018Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Jan 2009
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eltrombopag in immune thrombocytopenia (ITP), sponsored by Weill Cornell Medicine. Started Jan 2009; status: completed.
02
Drugs
eltrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT00902018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00902018.